Alpine 4 Holdings, Inc. (NASDAQ:ALPP) announced that its subsidiary, Alternative Laboratories, LLC, has secured a $1.9 million purchase order from a new client focusing on men’s health and anti-aging products.
The innovative incubation firm said it expects the order to be fulfilled in the fourth quarter of 2021 and the first quarter of 2022.
Alternative Laboratories (Alt Labs) is a private label dietary and nutritional supplement contract manufacturer located in Southwest Florida. Its mission is to provide its clients with successful, cutting-edge, and effective products, taking a transparent and solution-driven approach to the entire product development and manufacturing process.
READ: Alpine 4 debuts on the NASDAQ and acquires Identified Technologies
“The care and attention to detail implemented into manufacturing all of our customer's products is something Alt Labs is known for worldwide,” Alpine 4 CEO Kent Wilson said in a statement.
“This specific customer represents a distinct men's health product line that we haven't had the opportunity to pursue in the past. We are confident in growing this segment into a much larger sales opportunity in 2022 and beyond,” he added.
Alpine 4 Holdings is a NASDAQ traded conglomerate that acquires businesses that fit into its disruptive DSF business model of Drivers, Stabilizers, and Facilitators.
The company’s focus is on how the adaptation of new technologies, even in brick-and-mortar businesses, can drive innovation. It also believes that its holdings should benefit synergistically from each other, have the ability to collaborate across varying industries, spawn new ideas, and create fertile ground for competitive advantages.
Contact the author at stephen.gunnion@proactiveinvestors.com